At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 180 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- Not specified
- Who
- All
- Number of participants
- 1,000
- Started
- 2021-06-24
- Last checked
- 2025-01
Plain English Summary
What is this study?
- • Testing a new treatment for skin cancer
- • Clinical study - 1,000 participants
- • This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates
Who can take part?
- • Adults
- • Diagnosed with skin cancer
Where?
- • London - Royal London Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates. The study also aims to characterise side effects and the occurrence of Adverse Events and their relationship to the treatment.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: Not specified
- Who can join: All genders
What the study is looking for
- ✓Any patient who has been treated using Calcium Electroporation
- ✓Any patient who has been treated using Electrochemotherapy
- ✓Patients must be mentally capable of understanding the information given
- ✓Patients must give written agreement to take part.
See the full criteria
Where Is This Study? (1 UK site)
Royal London Hospital
London E1 1FR, United Kingdom
How to Get in Touch
SEAN H KINSELLA
Sponsor contactCONTACT
Declan Soden
Sponsor contactCONTACT
